Dragon, Joel S.

HRN: 07-96-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2025
CEFTAZIDIME 1GM (VIAL)
08/02/2025
08/09/2025
IV
500mg
Q8H
CRBSI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: